Last updated on February 2018

Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage:

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Subarachnoid Hemorrhage | Hyponatremia | Cerebrovascular Spasm
  • Age: Between 18 - 70 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Age 18 to 70 inclusive
  2. Hunt-Hess score of 1-5
  3. Glascow Come Scale 4-15
  4. Modified Fisher Grade 1-4
  5. At least one reactive pupil
  6. A brain CT/ MRI demonstrating SAH
  7. DSA (digital subtraction angiogram) or CTA confirmed presence of intracranial aneurysm
  8. The patient can be started on HTS within 72 hours of onset of symptoms of SAH
  9. Previously placed central line or having other indication for central line placement

Exclusion Criteria:

  1. Pregnancy, or inability to rule out pregnancy with a pregnancy test
  2. A normal head CT scan or a CT scan showing a bleed that is not SAH
  3. Spinal cord injury or other serious noncerebral injury
  4. Known seizure disorder
  5. Known brain disease (eg tumor, metastasis) or major psychiatric disorders (eg schizophrenia)
  6. Renal insufficiency (baseline Cr>1.5 mg/dl, CrCl<30 ml/min, CKD)
  7. Acute systolic dysfunction or congestive heart failure (CHF), with EF <30%
  8. Hematologic abnormalities or coagulopathy (PT>20, PTT>50, INR>1.5, or bleeding time>10sec)
  9. Clinically significant cardiovascular, hepatic or pulmonary disease that, in the opinion of the investigator, would compromise patient safety
  10. Other life-threatening injury that compromises patient survival through duration of study
  11. Patient unlikely to be available for follow-up at 6 months after trial conclusion
  12. Any concurrent relevant condition that makes the patient unsuitable for participation or follow-up
  13. Serum sodium > 155 mEq/L

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.